Search｜Photos & Images & Videos｜KYODO NEWS IMAGES INC

Bedbugs Study - Lyon

A researcher observes bedbugs in an electron microscope, study on bedbugs, at the biometrics and evolutionary biology laboratory, Lyon, France on October 5, 2023. The French environment ministry said bedbugs have made a resurgence since disappearing in the 1950s due to international travel and increased resistance to pesticides. Photo by Thibaut Durand/ABACAPRESS.COM

E

Bedbugs Study - Lyon

A researcher handles a bedbug farm, study on bedbugs, at the biometrics and evolutionary biology laboratory, Lyon, France on October 5, 2023. The French environment ministry said bedbugs have made a resurgence since disappearing in the 1950s due to international travel and increased resistance to pesticides. Photo by Thibaut Durand/ABACAPRESS.COM

E

Bedbugs Study - Lyon

Bedbugs are fed human blood through a process that recreates the conditions of human skin, study on bedbugs, at the biometrics and evolutionary biology laboratory, Lyon, France on October 5, 2023. The French environment ministry said bedbugs have made a resurgence since disappearing in the 1950s due to international travel and increased resistance to pesticides. Photo by Thibaut Durand/ABACAPRESS.COM

E

Bedbugs Study - Lyon

Researchers go through a security lock after handling bedbugs, study on bedbugs, at the biometrics and evolutionary biology laboratory, Lyon, France on October 5, 2023. The French environment ministry said bedbugs have made a resurgence since disappearing in the 1950s due to international travel and increased resistance to pesticides. Photo by Thibaut Durand/ABACAPRESS.COM

E

Bedbugs Study - Lyon

A researcher handles a bedbug farm, study on bedbugs, at the biometrics and evolutionary biology laboratory, Lyon, France on October 5, 2023. The French environment ministry said bedbugs have made a resurgence since disappearing in the 1950s due to international travel and increased resistance to pesticides. Photo by Thibaut Durand/ABACAPRESS.COM

E

Bedbugs Study - Lyon

Bedbugs are fed human blood through a process that recreates the conditions of human skin, study on bedbugs, at the biometrics and evolutionary biology laboratory, Lyon, France on October 5, 2023. The French environment ministry said bedbugs have made a resurgence since disappearing in the 1950s due to international travel and increased resistance to pesticides. Photo by Thibaut Durand/ABACAPRESS.COM

E

Bedbugs Study - Lyon

Bedbugs are fed human blood through a process that recreates the conditions of human skin, study on bedbugs, at the biometrics and evolutionary biology laboratory, Lyon, France on October 5, 2023. The French environment ministry said bedbugs have made a resurgence since disappearing in the 1950s due to international travel and increased resistance to pesticides. Photo by Thibaut Durand/ABACAPRESS.COM

E

Bedbugs Study - Lyon

A researcher pipettes blood on to heated media to recreate human blood conditions to feed bedbugs, study on bedbugs, at the biometrics and evolutionary biology laboratory, Lyon, France on October 5, 2023. The French environment ministry said bedbugs have made a resurgence since disappearing in the 1950s due to international travel and increased resistance to pesticides. Photo by Thibaut Durand/ABACAPRESS.COM

E

Bedbugs Study - Lyon

Conservation of bedbug breeding for medical research, study on bedbugs, at the biometrics and evolutionary biology laboratory, Lyon, France on October 5, 2023. The French environment ministry said bedbugs have made a resurgence since disappearing in the 1950s due to international travel and increased resistance to pesticides. Photo by Thibaut Durand/ABACAPRESS.COM

E

Bedbugs Study - Lyon

Researcher places membrane over blood to create conditions for bedbugs to feed on human skin, study on bedbugs, at the biometrics and evolutionary biology laboratory, Lyon, France on October 5, 2023. The French environment ministry said bedbugs have made a resurgence since disappearing in the 1950s due to international travel and increased resistance to pesticides. Photo by Thibaut Durand/ABACAPRESS.COM

E

Bedbugs Study - Lyon

Conservation of bedbug breeding for medical research, study on bedbugs, at the biometrics and evolutionary biology laboratory, Lyon, France on October 5, 2023. The French environment ministry said bedbugs have made a resurgence since disappearing in the 1950s due to international travel and increased resistance to pesticides. Photo by Thibaut Durand/ABACAPRESS.COM

E

Bedbugs Study - Lyon

Conservation of bedbug breeding for medical research, study on bedbugs, at the biometrics and evolutionary biology laboratory, Lyon, France on October 5, 2023. The French environment ministry said bedbugs have made a resurgence since disappearing in the 1950s due to international travel and increased resistance to pesticides. Photo by Thibaut Durand/ABACAPRESS.COM

E

Bedbugs Study - Lyon

Conservation of bedbug breeding for medical research, study on bedbugs, at the biometrics and evolutionary biology laboratory, Lyon, France on October 5, 2023. The French environment ministry said bedbugs have made a resurgence since disappearing in the 1950s due to international travel and increased resistance to pesticides. Photo by Thibaut Durand/ABACAPRESS.COM

E

Bedbugs Study - Lyon

A researcher observes bedbugs in an electron microscope, study on bedbugs, at the biometrics and evolutionary biology laboratory, Lyon, France on October 6, 2023. The French environment ministry said bedbugs have made a resurgence since disappearing in the 1950s due to international travel and increased resistance to pesticides. Photo by Thibaut Durand/ABACAPRESS.COM

E

Bedbugs Study - Lyon

A researcher observes bedbugs in an electron microscope, study on bedbugs, at the biometrics and evolutionary biology laboratory, Lyon, France on October 6, 2023. The French environment ministry said bedbugs have made a resurgence since disappearing in the 1950s due to international travel and increased resistance to pesticides. Photo by Thibaut Durand/ABACAPRESS.COM

E

Bedbugs Study - Lyon

A researcher observes bedbugs in an electron microscope, study on bedbugs, at the biometrics and evolutionary biology laboratory, Lyon, France on October 6, 2023. The French environment ministry said bedbugs have made a resurgence since disappearing in the 1950s due to international travel and increased resistance to pesticides. Photo by Thibaut Durand/ABACAPRESS.COM

E

Bedbugs Study - Lyon

A researcher observes bedbugs in an electron microscope, study on bedbugs, at the biometrics and evolutionary biology laboratory, Lyon, France on October 6, 2023. The French environment ministry said bedbugs have made a resurgence since disappearing in the 1950s due to international travel and increased resistance to pesticides. Photo by Thibaut Durand/ABACAPRESS.COM

E

Bedbugs Study - Lyon

A researcher observes bedbugs in an electron microscope, study on bedbugs, at the biometrics and evolutionary biology laboratory, Lyon, France on October 6, 2023. The French environment ministry said bedbugs have made a resurgence since disappearing in the 1950s due to international travel and increased resistance to pesticides. Photo by Thibaut Durand/ABACAPRESS.COM

E

Bedbugs Study - Lyon

A researcher observes bedbugs in an electron microscope, study on bedbugs, at the biometrics and evolutionary biology laboratory, Lyon, France on October 6, 2023. The French environment ministry said bedbugs have made a resurgence since disappearing in the 1950s due to international travel and increased resistance to pesticides. Photo by Thibaut Durand/ABACAPRESS.COM

E

Bedbugs Study - Lyon

Sample of bedbugs at different stages of embryonic development until adulthood, study on bedbugs, at the biometrics and evolutionary biology laboratory, Lyon, France on October 5, 2023. The French environment ministry said bedbugs have made a resurgence since disappearing in the 1950s due to international travel and increased resistance to pesticides. Photo by Thibaut Durand/ABACAPRESS.COM

E

Bedbugs Study - Lyon

A researcher observes bedbugs in an electron microscope, study on bedbugs, at the biometrics and evolutionary biology laboratory, Lyon, France on October 6, 2023. The French environment ministry said bedbugs have made a resurgence since disappearing in the 1950s due to international travel and increased resistance to pesticides. Photo by Thibaut Durand/ABACAPRESS.COM

E

China Biopharmaceutical,

Chinese biometrics are seen in a cluster of buildings in the Central Business District (CBD) in Beijing, China, on December 26, 2020. Sinovac Biotech Co., LTD., a subsidiary of Sinovac Biotech Co., LTD., received us $515 million for the further development, capacity expansion and production of novel Coronavirus inactivated vaccine and other development and operation activities of Sinovac. The investor, China Biopharmaceutical, an innovation-driven pharmaceutical group, will take a stake of about 15 per cent in The company.

E

China Biopharmaceutical,

Chinese biometrics are seen in a cluster of buildings in the Central Business District (CBD) in Beijing, China, on December 26, 2020. Sinovac Biotech Co., LTD., a subsidiary of Sinovac Biotech Co., LTD., received us $515 million for the further development, capacity expansion and production of novel Coronavirus inactivated vaccine and other development and operation activities of Sinovac. The investor, China Biopharmaceutical, an innovation-driven pharmaceutical group, will take a stake of about 15 per cent in The company.

E

China Biopharmaceutical,

Chinese biometrics are seen in a cluster of buildings in the Central Business District (CBD) in Beijing, China, on December 26, 2020. Sinovac Biotech Co., LTD., a subsidiary of Sinovac Biotech Co., LTD., received us $515 million for the further development, capacity expansion and production of novel Coronavirus inactivated vaccine and other development and operation activities of Sinovac. The investor, China Biopharmaceutical, an innovation-driven pharmaceutical group, will take a stake of about 15 per cent in The company.

E

China Biopharmaceutical,

Chinese biometrics are seen in a cluster of buildings in the Central Business District (CBD) in Beijing, China, on December 26, 2020. Sinovac Biotech Co., LTD., a subsidiary of Sinovac Biotech Co., LTD., received us $515 million for the further development, capacity expansion and production of novel Coronavirus inactivated vaccine and other development and operation activities of Sinovac. The investor, China Biopharmaceutical, an innovation-driven pharmaceutical group, will take a stake of about 15 per cent in The company.

E

China Biopharmaceutical,

Chinese biometrics are seen in a cluster of buildings in the Central Business District (CBD) in Beijing, China, on December 26, 2020. Sinovac Biotech Co., LTD., a subsidiary of Sinovac Biotech Co., LTD., received us $515 million for the further development, capacity expansion and production of novel Coronavirus inactivated vaccine and other development and operation activities of Sinovac. The investor, China Biopharmaceutical, an innovation-driven pharmaceutical group, will take a stake of about 15 per cent in The company.

E

China Biopharmaceutical,

Chinese biometrics are seen in a cluster of buildings in the Central Business District (CBD) in Beijing, China, on December 26, 2020. Sinovac Biotech Co., LTD., a subsidiary of Sinovac Biotech Co., LTD., received us $515 million for the further development, capacity expansion and production of novel Coronavirus inactivated vaccine and other development and operation activities of Sinovac. The investor, China Biopharmaceutical, an innovation-driven pharmaceutical group, will take a stake of about 15 per cent in The company.

E

China Biopharmaceutical,

Chinese biometrics are seen in a cluster of buildings in the Central Business District (CBD) in Beijing, China, on December 26, 2020. Sinovac Biotech Co., LTD., a subsidiary of Sinovac Biotech Co., LTD., received us $515 million for the further development, capacity expansion and production of novel Coronavirus inactivated vaccine and other development and operation activities of Sinovac. The investor, China Biopharmaceutical, an innovation-driven pharmaceutical group, will take a stake of about 15 per cent in The company.

E

China Biopharmaceutical,

Chinese biometrics are seen in a cluster of buildings in the Central Business District (CBD) in Beijing, China, on December 26, 2020. Sinovac Biotech Co., LTD., a subsidiary of Sinovac Biotech Co., LTD., received us $515 million for the further development, capacity expansion and production of novel Coronavirus inactivated vaccine and other development and operation activities of Sinovac. The investor, China Biopharmaceutical, an innovation-driven pharmaceutical group, will take a stake of about 15 per cent in The company.

E

China Biopharmaceutical,

Chinese biometrics are seen in a cluster of buildings in the Central Business District (CBD) in Beijing, China, on December 26, 2020. Sinovac Biotech Co., LTD., a subsidiary of Sinovac Biotech Co., LTD., received us $515 million for the further development, capacity expansion and production of novel Coronavirus inactivated vaccine and other development and operation activities of Sinovac. The investor, China Biopharmaceutical, an innovation-driven pharmaceutical group, will take a stake of about 15 per cent in The company.

E

China Biopharmaceutical,

Chinese biometrics are seen in a cluster of buildings in the Central Business District (CBD) in Beijing, China, on December 26, 2020. Sinovac Biotech Co., LTD., a subsidiary of Sinovac Biotech Co., LTD., received us $515 million for the further development, capacity expansion and production of novel Coronavirus inactivated vaccine and other development and operation activities of Sinovac. The investor, China Biopharmaceutical, an innovation-driven pharmaceutical group, will take a stake of about 15 per cent in The company.

E

China Biopharmaceutical,

Chinese biometrics are seen in a cluster of buildings in the Central Business District (CBD) in Beijing, China, on December 26, 2020. Sinovac Biotech Co., LTD., a subsidiary of Sinovac Biotech Co., LTD., received us $515 million for the further development, capacity expansion and production of novel Coronavirus inactivated vaccine and other development and operation activities of Sinovac. The investor, China Biopharmaceutical, an innovation-driven pharmaceutical group, will take a stake of about 15 per cent in The company.

E

China Biopharmaceutical,

Chinese biometrics are seen in a cluster of buildings in the Central Business District (CBD) in Beijing, China, on December 26, 2020. Sinovac Biotech Co., LTD., a subsidiary of Sinovac Biotech Co., LTD., received us $515 million for the further development, capacity expansion and production of novel Coronavirus inactivated vaccine and other development and operation activities of Sinovac. The investor, China Biopharmaceutical, an innovation-driven pharmaceutical group, will take a stake of about 15 per cent in The company.

E

China Biopharmaceutical,

Chinese biometrics are seen in a cluster of buildings in the Central Business District (CBD) in Beijing, China, on December 26, 2020. Sinovac Biotech Co., LTD., a subsidiary of Sinovac Biotech Co., LTD., received us $515 million for the further development, capacity expansion and production of novel Coronavirus inactivated vaccine and other development and operation activities of Sinovac. The investor, China Biopharmaceutical, an innovation-driven pharmaceutical group, will take a stake of about 15 per cent in The company.

E

China Biopharmaceutical,

Chinese biometrics are seen in a cluster of buildings in the Central Business District (CBD) in Beijing, China, on December 26, 2020. Sinovac Biotech Co., LTD., a subsidiary of Sinovac Biotech Co., LTD., received us $515 million for the further development, capacity expansion and production of novel Coronavirus inactivated vaccine and other development and operation activities of Sinovac. The investor, China Biopharmaceutical, an innovation-driven pharmaceutical group, will take a stake of about 15 per cent in The company.

E

China Biopharmaceutical,

Chinese biometrics are seen in a cluster of buildings in the Central Business District (CBD) in Beijing, China, on December 26, 2020. Sinovac Biotech Co., LTD., a subsidiary of Sinovac Biotech Co., LTD., received us $515 million for the further development, capacity expansion and production of novel Coronavirus inactivated vaccine and other development and operation activities of Sinovac. The investor, China Biopharmaceutical, an innovation-driven pharmaceutical group, will take a stake of about 15 per cent in The company.

E

China Biopharmaceutical,

Chinese biometrics are seen in a cluster of buildings in the Central Business District (CBD) in Beijing, China, on December 26, 2020. Sinovac Biotech Co., LTD., a subsidiary of Sinovac Biotech Co., LTD., received us $515 million for the further development, capacity expansion and production of novel Coronavirus inactivated vaccine and other development and operation activities of Sinovac. The investor, China Biopharmaceutical, an innovation-driven pharmaceutical group, will take a stake of about 15 per cent in The company.

E

China Biopharmaceutical,

Chinese biometrics are seen in a cluster of buildings in the Central Business District (CBD) in Beijing, China, on December 26, 2020. Sinovac Biotech Co., LTD., a subsidiary of Sinovac Biotech Co., LTD., received us $515 million for the further development, capacity expansion and production of novel Coronavirus inactivated vaccine and other development and operation activities of Sinovac. The investor, China Biopharmaceutical, an innovation-driven pharmaceutical group, will take a stake of about 15 per cent in The company.

E

China Biopharmaceutical,

Chinese biometrics are seen in a cluster of buildings in the Central Business District (CBD) in Beijing, China, on December 26, 2020. Sinovac Biotech Co., LTD., a subsidiary of Sinovac Biotech Co., LTD., received us $515 million for the further development, capacity expansion and production of novel Coronavirus inactivated vaccine and other development and operation activities of Sinovac. The investor, China Biopharmaceutical, an innovation-driven pharmaceutical group, will take a stake of about 15 per cent in The company.